Attention to and Distraction from Risk Information in Prescription Drug Advertising: An Eye Tracking Study
- PMID: 33505105
- PMCID: PMC7837323
- DOI: 10.1509/jppm.16.013
Attention to and Distraction from Risk Information in Prescription Drug Advertising: An Eye Tracking Study
Abstract
Direct-to-consumer (DTC) television ads must disclose a drug's most important risks. Currently, the risks must be in audio at a minimum. Studies have shown that presenting information with both audio and superimposed risk text (dual-modality) improves recall beyond that of using audio alone. However, distracting elements in DTC ads may draw attention away from the superimposed risk text. This study combined eye-tracking data with questionnaire data to examine whether distracting elements decrease attention to the risk text in DTC ads, in turn affecting risk retention and risk perceptions. The authors randomly assigned 300 U.S. opt-in panel members to view either a low-distraction or a high-distraction DTC television ad. The authors found that distracting elements during risk presentation drew attention away from the risk text and, in turn, reduced retention of drug risk information. Risk perceptions were not affected. These results suggest that even if dual-modality is used to increase consumer's comprehension of drug risk information, distracting visuals should still be avoided in order to help consumers focus on key information in the ad.
Keywords: direct-to-consumer advertising; distraction; eye tracking; prescription drug.
Figures



Similar articles
-
The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.Med Decis Making. 2019 Nov;39(8):975-985. doi: 10.1177/0272989X19875946. Epub 2019 Oct 4. Med Decis Making. 2019. PMID: 31583947 Free PMC article. Clinical Trial.
-
Consumer responses to framing statements preceding the major risk statement in prescription drug DTC TV ads.Res Social Adm Pharm. 2020 Sep;16(9):1237-1247. doi: 10.1016/j.sapharm.2019.11.018. Epub 2019 Nov 30. Res Social Adm Pharm. 2020. PMID: 31838056
-
Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.Soc Sci Med. 2014 Nov;120:1-11. doi: 10.1016/j.socscimed.2014.08.039. Epub 2014 Aug 28. Soc Sci Med. 2014. PMID: 25194471 Free PMC article.
-
Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.Pharmacoeconomics. 2001;19(2):109-19. doi: 10.2165/00019053-200119020-00001. Pharmacoeconomics. 2001. PMID: 11284378 Review.
-
What nurse practitioners should know about direct-to-consumer advertising of prescription medications.J Am Acad Nurse Pract. 2003 Jul;15(7):297-304. doi: 10.1111/j.1745-7599.2003.tb01312.x. J Am Acad Nurse Pract. 2003. PMID: 12929250 Review.
Cited by 1 article
-
Assessing the Inclusion of Foil Items in a Scale to Measure Recognition of Health Messages.Commun Methods Meas. 2021 Jul 3;15(3):10.1080/19312458.2020.1768520. doi: 10.1080/19312458.2020.1768520. Commun Methods Meas. 2021. PMID: 34616499
Grant support
LinkOut - more resources
Full Text Sources